|
Catalog Number UNK VOLIFT |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Respiratory Tract Infection (2420)
|
Event Date 07/19/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The event of "sinusitis (left sinus)¿ (not device related) is considered an unexpected adverse drug experience.Allergan is unable to confirm with the healthcare professional; therefore, additional event, product, or patient details are not attainable.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The filler was injected into the patient and is not accessible for return.The syringe was discarded.
|
|
Event Description
|
Healthcare professional reported that a clinical patient was injected in the hands with juvéderm® volift® with lidocaine.Approximately a month later, patient was infected with covid-19, deemed not related to the device and non-serious.Patient was treated with ¿doliprane 1g" and event resolved 15 days from date of onset.Patient has a first covid-19 vaccine approximately five months later.It was further noted that patient experienced inflammatory reaction on both hands 13 days after covid-19 vaccination.Patient was treated with aerius, augmentin 500mg, solupred 20mg, mopral, and cytolnat.Approximately two weeks later, patient experienced feverish gastroenteritis, deemed not related to the device and non-serious.Patient was treated with doliprane 1000mg and event resolved 11 days after onset.Approximately less than a month later, patient experienced sinusitis (left sinus), deemed not related to the device.Patient was treated with amoxicillin 1g and event resolved five days later.
|
|
Event Description
|
Healthcare professional reported that a clinical patient was injected in the hands with juvéderm® volift® with lidocaine.Approximately a month later, patient was infected with covid-19, deemed not related to the device and non-serious.Patient was treated with ¿doliprane 1g" and event resolved 15 days from date of onset.Patient has a first covid-19 vaccine approximately five months later.It was further noted that patient experienced inflammatory reaction on both hands 13 days after covid-19 vaccination.Patient was treated with aerius, augmentin 500mg, solupred 20mg, mopral, and cytolnat.Approximately two weeks later, patient experienced feverish gastroenteritis, deemed not related to the device and non-serious.Patient was treated with doliprane 1000mg and event resolved 11 days after onset.Approximately less than a month later, patient experienced sinusitis (left sinus), deemed not related to the device.Patient was treated with amoxicillin 1g and event resolved five days later.
|
|
Search Alerts/Recalls
|
|
|